Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Mem. Inst. Oswaldo Cruz ; 102(3): 377-384, June 2007. graf, tab
Article in English | LILACS | ID: lil-452518

ABSTRACT

In Plasmodium falciparum, the formation of isopentenyl diphosphate and dimethylallyl diphosphate, central intermediates in the biosynthesis of isoprenoids, occurs via the methylerythritol phosphate (MEP) pathway. Fosmidomycin is a specific inhibitor of the second enzyme of the MEP pathway, 1-deoxy-D-xylulose-5-phosphate reductoisomerase. We analyzed the effect of fosmidomycin on the levels of each intermediate and its metabolic requirement for the isoprenoid biosynthesis, such as dolichols and ubiquinones, throughout the intraerythrocytic cycle of P. falciparum. The steady-state RNA levels of the MEP pathway-associated genes were quantified by real-time polymerase chain reaction and correlated with the related metabolite levels. Our results indicate that MEP pathway metabolite peak precede maximum transcript abundance during the intraerythrocytic cycle. Fosmidomycin-treatment resulted in a decrease of the intermediate levels in the MEP pathway as well as in ubiquinone and dolichol biosynthesis. The MEP pathway associated transcripts were modestly altered by the drug, indicating that the parasite is not strongly responsive at the transcriptional level. This is the first study that compares the effect of fosmidomycin on the metabolic and transcript profiles in P. falciparum, which has only the MEP pathway for isoprenoid biosynthesis.


Subject(s)
Animals , Erythritol/analogs & derivatives , Erythritol/metabolism , Erythrocytes/parasitology , Fosfomycin/analogs & derivatives , Fosfomycin/pharmacology , Plasmodium falciparum/metabolism , Sugar Phosphates/metabolism , Genes, Protozoan , Polymerase Chain Reaction , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics , Plasmodium falciparum/growth & development
2.
Genet. mol. res. (Online) ; 3(1): 85-91, Mar. 2004.
Article in English | LILACS | ID: lil-417582

ABSTRACT

Chromobacterium violaceum presents a distinctive phenotypic characteristic, the production of a deep violet pigment named violacein. Although the physiological function of this pigment is not well understood, the sequencing of the genome of this bacterium has given some insight into the mechanisms and control of violacein production. It was found that erythrose-4-phosphate (E4P), a precursor to aromatic amino acid biosynthesis, is produced by the non-oxidative portion of the hexose monophosphate pathway, since it lacks 6-phosphogluconate dehydrogenase. All genes leading from E4P plus phosphoenolpyruvate to tryptophan are present in the genome. Nevertheless, these genes are not organized in an operon, as in E. coli, indicating that other mechanisms are involved in expression. The sequencing data also indicated the presence and organization of an operon for violacein biosynthesis. Three of the four gene products of this operon presented similarity with nucleotide-dependent monooxygenases and one with a limiting enzyme polyketide synthase. As previously suggested, genes encoding proteins involved in quorum sensing control by N-hexanoyl-homoserine-lactone, an autoinducer signal molecule, are present in the bacterial genome. These data should help guide strategies to increase violacein biosynthesis, a potentially useful molecule


Subject(s)
Chromobacterium/genetics , Indoles/metabolism , Chromobacterium/metabolism , Multienzyme Complexes/biosynthesis , Multienzyme Complexes/genetics , Sugar Phosphates/genetics , Sugar Phosphates/metabolism , Carboxylic Ester Hydrolases/biosynthesis , Carboxylic Ester Hydrolases/genetics , Indoles/chemistry , Tryptophan/biosynthesis , Tryptophan/genetics
SELECTION OF CITATIONS
SEARCH DETAIL